TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Ytterby Life Science AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,376
|
1,258 | |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
343
|
343 | |
| EBITDA |
231
|
243 | |
| Total assets |
611
|
543 | |
| Current assets |
581
|
513 | |
| Current liabilities |
58
|
53 | |
| Equity capital |
496
|
448 | |
| - share capital |
50
|
50 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
81.2%
|
82.5% | |
| Turnover per employee |
1,376
|
1,258 | |
| Profit as a percentage of turnover |
24.9%
|
27.3% | |
| Return on assets (ROA) |
56.1%
|
63.2% | |
| Current ratio |
1001.7%
|
967.9% | |
| Return on equity (ROE) |
69.2%
|
76.6% | |
| Change turnover |
118
|
187 | |
| Change turnover % |
-21%
|
9%
|
17% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.